ClinGen expert panel — InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP
Benign for familial adenomatous polyposis 1. Applied ACMG criteria (verbatim):
BP7 BP4 BA1
Curation rationale (ClinGen, verbatim)
The c.1458T>C (p.Tyr486=) variant in APC is a synonymous (silent) variant that is not predicted to impact splicing (BP4, BP7). The highest population minor allele frequency (non-cancer) in gnomAD v2.1.1 is 69.75% in Latino/Admixed American population, which is higher than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel (HCCP VCEP) threshold (≥ 0.1%) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: BA1, BP4, BP7 (VCEP specifications Version 1.0, date of approval: 12/12/2022).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -0.023 | GERP -2, phastCons 0.92 |
| Overall | ||
| CADD | 7.126 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 70.8% | 1 |
| Admixed American | 67.3% | 1 |
| South Asian | 63.9% | 2 |
| Amishnot grpmax-eligible | 63% | 2 |
| European (non-Finnish) | 59.1% | 2 |
| Remaining individualsnot grpmax-eligible | 57.1% | 2 |
| Ashkenazi Jewishnot grpmax-eligible | 56.2% | 2 |
| Middle Eastern | 55.4% | 2 |
| Finnishnot grpmax-eligible | 51.1% | 2 |
| African / African-American | 19.9% | 5 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- APC
- Protein
- p.Tyr486=
- Coding
- c.1458T>C
- MANE Select
- NM_000038
- dbSNP
- rs2229992
- Type
- single nucleotide variant
- Location
- chr5:112827157 (GRCh38)
- Gene constraint
- LOEUF 0.321 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Residue 486
- an α-helix
Disease context
familial adenomatous polyposis 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: colon carcinomahepatocellular carcinomahereditary neoplastic syndromegastric neoplasmfamilial colorectal cancer
For Familial adenomatous polyposis (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- Adult
- Prevalence
- 1-9 / 100 000 (Worldwide)
Similar variants
- APC p.Tyr486Ter Pathogenic ★ same residue
- APC p.Tyr486Cys Uncertain significance ★ same residue
- APC p.Tyr486His Uncertain significance ★ ⚠ same residue
- APC p.Tyr486Phe Uncertain significance ★ same residue
- APC c.1312+3A>C Likely pathogenic ★★★ same condition
- APC c.1312+3A>G Pathogenic ★★★ same condition
- APC c.1312+5G>A Likely pathogenic ★★★ same condition
- APC c.1312+5G>C Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/apc-p-tyr486 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown